| Julie Logan, LCSW-C | |
|
21770 Fdr Blvd, Lexington Park, MD 20653-1558 | |
| (301) 863-6661 | |
| (301) 866-9189 |
| Full Name | Julie Logan |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 29 Years |
| Location | 21770 Fdr Blvd, Lexington Park, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922340470 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 13460 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pathways Inc | 8527160597 | 15 |
News Archive
Enzymes linked to diabetes and obesity appear to play key roles in arthritis and leukemia, potentially opening up new avenues for treating these diverse diseases, according to new research at Washington University School of Medicine in St. Louis.
Wistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for the treatment of diseases such as leukemia, as a new therapeutic option for ovarian cancer with mutations in the ARID1A gene.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that interim data from its ongoing clinical study of the EndoBarrier™ Gastrointestinal Liner in obese patients with type 2 diabetes will be presented by Eduardo G. Moura, M.D., Ph.D., director of endoscopy, digestive surgery department, Hospital das Clinicas, University of Sao Paulo, on Monday, November 23, 2009 at GASTRO 2009.
Contralateral prophylactic mastectomy (CPM), a preventive procedure to remove the unaffected breast in patients with disease in one breast, may only offer a survival benefit to breast cancer patients age 50 and younger, who have early-stage disease and are estrogen receptor (ER) negative, according to researchers at The University of Texas M. D. Anderson Cancer Center.
A recent Lancet article predicted a doubling of new cases of type 1 diabetes in European children aged under 5, and a 70% rise in cases in children under 15 years - an incidence rate exceeding all previous predictions. Studies in the USA and other countries also suggest similar trends.
› Verified 5 days ago
| Entity Name | Pathways Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043229875 PECOS PAC ID: 8527160597 Enrollment ID: O20070221000427 |
News Archive
Enzymes linked to diabetes and obesity appear to play key roles in arthritis and leukemia, potentially opening up new avenues for treating these diverse diseases, according to new research at Washington University School of Medicine in St. Louis.
Wistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for the treatment of diseases such as leukemia, as a new therapeutic option for ovarian cancer with mutations in the ARID1A gene.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that interim data from its ongoing clinical study of the EndoBarrier™ Gastrointestinal Liner in obese patients with type 2 diabetes will be presented by Eduardo G. Moura, M.D., Ph.D., director of endoscopy, digestive surgery department, Hospital das Clinicas, University of Sao Paulo, on Monday, November 23, 2009 at GASTRO 2009.
Contralateral prophylactic mastectomy (CPM), a preventive procedure to remove the unaffected breast in patients with disease in one breast, may only offer a survival benefit to breast cancer patients age 50 and younger, who have early-stage disease and are estrogen receptor (ER) negative, according to researchers at The University of Texas M. D. Anderson Cancer Center.
A recent Lancet article predicted a doubling of new cases of type 1 diabetes in European children aged under 5, and a 70% rise in cases in children under 15 years - an incidence rate exceeding all previous predictions. Studies in the USA and other countries also suggest similar trends.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julie Logan, LCSW-C 30007 Business Center Dr, Charlotte Hall, MD 20622-3101 Ph: (301) 997-1300 | Julie Logan, LCSW-C 21770 Fdr Blvd, Lexington Park, MD 20653-1558 Ph: (301) 863-6661 |
News Archive
Enzymes linked to diabetes and obesity appear to play key roles in arthritis and leukemia, potentially opening up new avenues for treating these diverse diseases, according to new research at Washington University School of Medicine in St. Louis.
Wistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for the treatment of diseases such as leukemia, as a new therapeutic option for ovarian cancer with mutations in the ARID1A gene.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that interim data from its ongoing clinical study of the EndoBarrier™ Gastrointestinal Liner in obese patients with type 2 diabetes will be presented by Eduardo G. Moura, M.D., Ph.D., director of endoscopy, digestive surgery department, Hospital das Clinicas, University of Sao Paulo, on Monday, November 23, 2009 at GASTRO 2009.
Contralateral prophylactic mastectomy (CPM), a preventive procedure to remove the unaffected breast in patients with disease in one breast, may only offer a survival benefit to breast cancer patients age 50 and younger, who have early-stage disease and are estrogen receptor (ER) negative, according to researchers at The University of Texas M. D. Anderson Cancer Center.
A recent Lancet article predicted a doubling of new cases of type 1 diabetes in European children aged under 5, and a 70% rise in cases in children under 15 years - an incidence rate exceeding all previous predictions. Studies in the USA and other countries also suggest similar trends.
› Verified 5 days ago
Gabrielle Bollino, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 21770 Fdr Blvd, Lexington Park, MD 20653 Phone: 301-997-1300 | |
Elizabeth L Ramsey, LCSW-C, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 22776 Three Notch Rd, Suite 102, Lexington Park, MD 20653 Phone: 301-880-4833 | |
Susan Bearns, LGSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 21770 Fdr Blvd, Lexington Park, MD 20653 Phone: 301-997-1300 Fax: 301-997-1300 | |
Andrea Mcdonald-fingland, LLCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 21770 Fdr Blvd, Lexington Park, MD 20653 Phone: 301-997-1300 Fax: 301-866-9189 | |
Lisa Wojnarowski, LISW-CP Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 48050 Freehold Dr, Lexington Park, MD 20653 Phone: 847-732-3996 | |
Janis G Pressley, LCW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 21770 Fdr Boulevard, Lexington Park, MD 20653 Phone: 301-862-4961 Fax: 301-862-5554 | |
Mrs. Vicki Joan Majors, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 45727 Red Oak Rd, Lexington Park, MD 20653 Phone: 817-707-2266 |